Materials and methods Study design and data sources This cross-sectional study analyzed publicly available data from three sources: ClinicalTrials.gov for GLP-1 receptor agonist trial eligibility criteria, the US National Health and Nutrition Examination Survey (NHANES) 20212023, and the Korea National Health and Nutrition Examination Survey (KNHANES) 20212023
development as an obesity drug was not continued
This innovative program will integrate GLP-1 medication management with cognitive behavioral therapy and nutritional guidance, taking a holistic approach to improving member health outcomes
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
To learn more about the effects of Ozempic, make an appointment or visit Allied Digestive Health for more information
When both back and abdominal pain strike, you might wonder whats up